The revenue stands at ₹1,794.16 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.34 per cent from ₹1,625.96 crore. This corresponds to a year-on-year *(YoY) growth of 32.53 per cent.
Operating Profit stands at ₹547.56 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.27 per cent from ₹423.58 crore. This corresponds to a year-on-year *(YoY) growth of 67.03 per cent.
PBDT stands at ₹582.71 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.61 per cent from ₹491.30 crore. This corresponds to a year-on-year *(YoY) growth of 51.83 per cent.
Profit Before Tax stands at ₹535.15 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.77 per cent from ₹446.80 crore. This corresponds to a year-on-year *(YoY) growth of 57.02 per cent.
Net Profit stands at ₹388.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 16.13 per cent from ₹334.22 crore. This represents a 49.18 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -0.99% | -5.14% | -5.91% | -4.55% | 13.14% | 29.95% |
| Anthem Bioscienc | 2.19% | 5.51% | 2.92% | 6.18% | 15.23% | 25.80% |
| Glaxosmi. Pharma | -1.97% | 0.24% | -7.77% | -1.75% | 6.75% | -2.66% |
| Emcure Pharma | 9.67% | 16.66% | 12.15% | 10.98% | 28.54% | 59.73% |
| Sai Life | -0.34% | 3.60% | 2.45% | 11.15% | 43.20% | 77.10% |
| Piramal Pharma | 1.56% | 2.99% | 21.86% | 15.01% | 48.62% | 19.35% |
| Acutaas Chemical | -3.01% | -5.07% | 21.19% | 15.10% | 42.34% | 113.79% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah